Dr. Jeffrey I. Stewart, MD

Dr. Stewart practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Stewart's NPI, 1982805735, was assigned on May 30, 2007. Dr. Stewart graduated from Drexel University College of Medicine in 2007. Dr. Stewart holds New Hampshire license 22707.

Dr. Stewart's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Stewart's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Stewart is also affiliated with Alice Peck Day Memorial Hospital. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Stewart to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stewart practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Stewart's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Stewart's licenses on file in 2 states: New Hampshire and Pennsylvania.

CMS data shows 1,206 Medicare services from Dr. Stewart across 12 procedure codes in 2024, for 513 Medicare patients. Medicare paid $82,438 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 513 Medicare patients who saw Dr. Stewart in 2024. The largest group is 65 to 74, with 229 patients. 74% of them have high blood pressure, and 62% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stewart's median patient age at 66, with 57% women.

In 2024, Dr. Stewart wrote 2,613 Medicare Part D claims for 331 patients. CMS names the drug for 2,390 of them, across 49 drugs with 11 or more claims each, at $8,380,924 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Stewart for performance year 2024, reported through an alternative payment model (APM). Dr. Stewart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stewart as offering telehealth.

Dmand AI links 7 papers to Dr. Stewart, published from 2012 to 2022. The most frequent topics are Disease Progression, Hypertension, Pulmonary and Pulmonary Disease, Chronic Obstructive. Dr. Stewart's most frequent co-authors are Robert P. Baughman, MD, Gerard Criner, MD and Rohit Gupta, MD.

Dmand AI links Dr. Stewart to 5 clinical trials, 3 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Pulmonary Fibrosis, Familial Primary Pulmonary Hypertension and Hypertension, Pulmonary. United Therapeutics sponsors the most, 3.

CMS Open Payments shows 16 general payments to Dr. Stewart from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 65% of the total. United Therapeutics Corporation paid the most, $554.

Dr. Stewart graduated from Drexel University College of Medicine in 2007.